Evidence map›Paper›PMID 41018695›Full record

ArticleOpen forum infectious diseases2025

The Majority of

Ryuichi Minoda Sada, Go Yamamoto, Shigeto Hamaguchi, Eisuke Kuroda, Akiko Okura, Manke Cai, Kotone Nakanishi, Noriyuki Abe, Shungo Yamamoto, Satoshi Kutsuna

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ryuichi Minoda SadaDepartment of Transformative Protection to Infectious Disease, Graduate School of Medicine, The University of Osaka, Osaka, Japan.ORCID https://orcid.org/0000-0002-1455-6822
Go YamamotoDepartment of Transformative Protection to Infectious Disease, Graduate School of Medicine, The University of Osaka, Osaka, Japan.ORCID https://orcid.org/0009-0000-8007-3215
Shigeto HamaguchiDepartment of Infection Control and Prevention, Graduate School of Medicine, The University of Osaka, Osaka, Japan.ORCID https://orcid.org/0000-0003-2560-9982
Eisuke KurodaDepartment of Transformative Protection to Infectious Disease, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
Akiko OkuraDepartment of Transformative Protection to Infectious Disease, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
Manke CaiDepartment of Infection Control and Prevention, Graduate School of Medicine, The University of Osaka, Osaka, Japan.ORCID https://orcid.org/0009-0000-2136-5111
Kotone NakanishiDepartment of Clinical Microbiology, Clinical Laboratory Medicine, Tenri Hospital, Tenri, Japan.
Noriyuki AbeDepartment of Clinical Microbiology, Clinical Laboratory Medicine, Tenri Hospital, Tenri, Japan.
Shungo YamamotoDepartment of Transformative Protection to Infectious Disease, Graduate School of Medicine, The University of Osaka, Osaka, Japan.ORCID https://orcid.org/0000-0003-3207-8403
Satoshi KutsunaDepartment of Transformative Protection to Infectious Disease, Graduate School of Medicine, The University of Osaka, Osaka, Japan.ORCID https://orcid.org/0000-0002-6929-8955

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Natto consumption has been associated with improved cardiovascular and survival outcomes. Methods: This retrospective cohort study analyzed medical records of patients with positive Results: Of 4634 positive blood cultures, 70 (1.5%) were identified as Conclusions: Most

Indexed as

Bacillus subtilisbacteremiabloodstream infectionmortalitynatto

Identifiers

PMID41018695
PMCPMC12464813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.